FDA recall D-0874-2026 · Oct 7, 2026
Aurolab Trust: FOCUS PI Hypromellose 0 recall
Product
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Reason for recall
Lack of Assurance of Sterility
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your package, and look for the company's notice on FDA's recalls page. If you have the product and aren't sure, don't use it until you've checked.
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28
- Quantity
- 25,220 bottles
- Distribution
- VA
- Recalling firm
- Aurolab Trust, Madurai
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-09-17
Source: openFDA enforcement record D-0874-2026 · search recall number D-0874-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Oct 14, 2026, 12:58 AM EDT. The agency notice is the final word.
Check something else